The Dutch technology-health company said its performance was hit by cost inflation that was partly offset by pricing and productivity measures.
Read Full Story
Latest posts by Market Watch (see all)
- The Ratings Game: Marqeta’s stock pops as analyst says it presents ‘too compelling’ an opportunity - March 27, 2023
- Mark Hulbert: What the ‘Single Greatest Predictor of Future Stock Market Returns’ says about stocks - March 27, 2023
- : Fed raised concerns over SVB risk management as early as 2021, Vice Chair Barr says - March 27, 2023